In colorectal cancer studies, ISG15 altered NF-κB signalling by conjugating to key signalling proteins such as IκBα (inhibitor of κB alpha) and p65 (a subunit of NF-κB), thereby causing inhibition of apoptosis [29]. Here, NFKB1 is linked to colorectal cancer.